|
(P1853) |
CCR5del32 Genotype as a Predictive Marker for Human Enteroviral Cardiomyopathy |
| |
|
D. Lassner, C. S. Siegismund, M. Rohde, U. Kühl, R. Kurucz, C. Tschöpe, F. Escher, H.-P. Schultheiss (Berlin) |
|
(P1854) |
Cardioprotective effects of telbivudine in transcriptional active parvovirus B19 (B19V) |
| |
|
C. Tschöpe, S. Van Linthout, D. Lassner, M. Rohde, H.-P. Schultheiss, U. Kühl (Berlin) |
|
(P1855) |
Antibody-based targeted delivery of interleukin-10 to cardiac allograft vasculopathy and interstitial fibrosis in a heterotopic rat heart transplantation model |
| |
|
M. Franz, F. Doll, K. Grün, P. Richter, N. Köse, B. Ziffels, H. Schubert, C. Jung, J. Gummert, A. Renner, A. Berndt, H.-R. Figulla (Jena, Bad Oeynhausen; Zürich, CH) |
|
(P1856) |
Regulation of soluble receptor for advanced glycation end products (sRAGE) in myocarditis and dilated cardiomyopathy |
| |
|
S.-R. Selejan, A.-M. Tatu, S. Ewen, A. Kazakov, C. Ukena, K. Klingel, R. Kandolf, M. Böhm, I. Kindermann (Homburg/Saar, Tübingen) |
|
(P1857) |
Effects of immunoadsorption with subsequent immunoglobuline substitution on cardiac gene expression and protein levels in patients suffering from dilated cardiomyopathy |
| |
|
S. Ameling, E. Hammer, G. Bhardwaj, L. Steil, L. R. Herda, C. Trimpert, M. Grube, K. Klingel, R. Kandolf, M. Dörr, S. B. Felix, U. Völker (Greifswald, Tübingen) |
|
(P1858) |
Critical role of receptor for advanced glycation end products and its ligand high mobility group box 1 in inflammatory heart disease |
| |
|
A. Bangert, M. Andrassy, H. C. Volz, A.-M. Mueller, C. Leib, M. Bockstahler, R. Öttl, A. Fischer, O. J. Müller, F. Lasitschka, A. Bierhaus, H. A. Katus, Z. Kaya (Heidelberg) |
|
(P1859) |
Clinical profile of patients with advanced age and biopsy proven inflammatoric dilated cardiomyopathy |
| |
|
M.-A. Ohlow, T.-H. Chen, H. von Korn, A. Farah, M. Schreiber, S. Richter, M. El Garhy, B. Lauer (Bad Berka, Neustadt, Dortmund) |
|
(P1860) |
Perforin is an independent risk factor for survival in patients with suspected inflammatory cardiomyopathy |
| |
|
F. Escher, U. Kühl, D. Lassner, A. Stroux, D. Westermann, W. Poller, H.-P. Schultheiss, C. Tschöpe (Berlin, Hamburg) |
|
(P1861) |
Systematische Erfassung der T-Zell-Rezeptor Vbeta Dominanz bei experimenteller Myokarditis, humaner Myokarditis und dilatativer / inflammatorischer Kardiomyopathie |
| |
|
M. Noutsias, R. Pistulli, H.-R. Figulla, V. Patil, C. Konstas (Jena, Marburg) |
|
(P1862) |
Myocardial gene expression and miRNA analyses in patients with inflammatory vs. idiopathic dilated cardiomyopathy: specific transcriptomes in different non-ischemic cardiac diseases |
| |
|
S. Becker, E. Schaeffeler, A. R. Florian, S. Rösch, S. Winter, U. Sechtem, M. Schwab, A. Yilmaz (Stuttgart, Münster, Tübingen) |
|
(P1863) |
ELCiD – Erkennen und Lenken von Chagas-Patienten in Deutschland |
| |
|
J. Strasen, M. Pritsch, O. Ritter, M. Bender, M. Wirth, J. Sauer, M. Hanke, D. Tempel, M. Kaspar, S. Parisi, S. Störk, N. Behrens-Riha, A. Stich, T. Zoller (Würzburg, München, Mönchengladbach, Berlin) |
|
(P1864) |
Nutzen der 3D transösophagealen Echokardiographie im Rahmen der Diagnostik der infektiösen Endokarditis – eine prospektive Kohortenstudie |
| |
|
Y. Betton, R. Pfister, N. Jung, S. Baldus, G. Michels (Köln) |
|
(P1865) |
Accuracy of 2D strain echocardiography compared to cardiac magnetic resonance in the diagnostic of inflammatory cardiomyopathy as proven by endomyocardial biopsy |
| |
|
M. Kasner, A. S. Aleksandrov, U. Kühl, N. Al-Saadi, H.-P. Schultheiss, C. Tschöpe (Berlin) |